PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 200 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $412,000 | -28.1% | 13,216 | +5.3% | 0.02% | -24.1% |
| Q4 2017 | $573,000 | +122.1% | 12,552 | +83.0% | 0.03% | +123.1% |
| Q3 2017 | $258,000 | -21.1% | 6,860 | +0.1% | 0.01% | -7.1% |
| Q2 2017 | $327,000 | +11.6% | 6,850 | +6.8% | 0.01% | +7.7% |
| Q1 2017 | $293,000 | +36.9% | 6,415 | -3.2% | 0.01% | +44.4% |
| Q4 2016 | $214,000 | -39.0% | 6,625 | +33.3% | 0.01% | -30.8% |
| Q2 2015 | $351,000 | -91.6% | 4,970 | -89.4% | 0.01% | -90.5% |
| Q1 2015 | $4,161,000 | +4.0% | 46,831 | +3.8% | 0.14% | +7.0% |
| Q4 2014 | $4,000,000 | +64.7% | 45,121 | +80.1% | 0.13% | +60.0% |
| Q3 2014 | $2,429,000 | +1.9% | 25,059 | -3.4% | 0.08% | +11.1% |
| Q2 2014 | $2,383,000 | – | 25,945 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |